EN CN
News
Elpiscience Announces Five Poster Presentations at Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
October 26,2022 PDF Version

SHANGHAI, China and SUZHOU, China and GERMANTOWN, MD., Oct. 20, 2022 – Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide, today announced it will have five poster presentations at the SITC 2022 Annual Meeting being held in Boston, Massachusetts from November 8-12. The posters will highlight preclinical studies on five innovative molecules including anti-SIRPα monoclonal antibody ES004, anti-LAG3 monoclonal antibody ES005, anti-LILRB2 monoclonal antibody ES009, anti-SIGLEC15 antibody ES012, and PD-L1/SIRPα bispecific macrophage engager ES019.

 

Poster presentations:

1.

Title: ES005, a high affinity anti-LAG3 monoclonal antibody, inhibits the interactions between LAG3 and multiple ligands and enhances anti-tumor activity of T cells in preclinical models

Abstract No.: 426

Date and time: 11/11/2022, 9:00 am - 9:00 pm (EST)

 

2.

Title: ES009, a LILRB2-specific blocking antibody, reprograms myeloid cells into pro-inflammation phenotype and potentiates T cell activation

Abstract No.: 1062 

Date and time: 11/11/2022, 9:00 am - 9:00 pm (EST)

 

3.

Title: Treatment of anti-SIRPα in combination with anti-TAA exerts superior anti-tumor activity

Abstract No.: 793 

Date and time: 11/10/2022, 9:00 am - 9:00 pm (EST)

 

4.

Title: Dual targeting of innate and adaptive immune checkpoints with a PD-L1/SIRPα bispecific macrophage engager to promote anti-tumor activity 

Abstract No.: 1211

Date and time: 11/10/2022, 9:00 am - 9:00 pm (EST)

 

5.

Title: SIGLEC15 induces monocyte apoptosis and an SIGLEC15 antibody ES012 reverses myeloid cells driven immunosuppression

Abstract No.: 1401

Date and time: 11/10/2022, 9:00 am - 9:00 pm (EST)

Contact Us

Corporate Communications:
PR@elpiscience.com

Investor Relation:
IR@elpiscience.com